SBI Securities »

AgomAb Therapeutics NV shares owned by SBI Securities

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $21 2 10.50

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Tesla Motors (TSLA)
Alphabet Inc Class A cs (GOOGL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
SPDR Gold MiniShares Trust Etf (GLDM)
Alphabet Inc Class C cs (GOOG)

View all positions for SBI Securities

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
Nantahala Capital Management
Standard Life Aberdeen
Samsara BioCapital
Perceptive Advisors
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management
Alyeska Investment Group

View all funds holding AgomAb Therapeutics NV